Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?

Journal of Affective Disorders

Volumn 94, Issue 1-3, 2006, Pages 105-110

  Akiskal, Hagop S ^a   Benazzi, Franco ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Hecker Psychiatry Research Center   (Italy)

^c UNIVERSITY OF SZEGED   (Hungary)

^d DEPARTMENT OF PSYCHIATRY   (Italy)

Author keywords

Bipolar II disorder; Depression; Depressive mixed state; Racing crowded thoughts; Suicidality

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BIPOLAR II DISORDER; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; FAMILY HISTORY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPOMANIA; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MIXED MANIA AND DEPRESSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PRIVATE PRACTICE; PSYCHIATRIC DIAGNOSIS; RESTLESSNESS; SCREENING; STRUCTURED INTERVIEW; SUICIDAL IDEATION; SUICIDE; THOUGHT DISORDER; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIVATE PRACTICE; RISK FACTORS; STATISTICS; STATISTICS AS TOPIC; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33746227775     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.04.002     Document Type: Article

References (42)

1. Akiskal H.S. Demystifying borderline personality: critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatr. Scand. 110 (2004) 401-407
2. Akiskal H.S., and Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. Bull. 23 (1987) 68-73
3. Akiskal H.S., and Pinto O. The evolving bipolar spectrum: prototypes I, II, III, IV. Psychiatr. Clin. North Am. 22 (1999) 517-534
4. Akiskal H.S., and Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J. Affect. Disord. 73 (2003) 113-122
5. Akiskal H.S., and Benazzi F. Delineating depressive mixed states: their therapeutic significance. Clin. Approach. Bipolar Disord. 2 (2003) 41-47
6. Akiskal H.S., and Benazzi F. Validating Kraepelin's two types of depressive mixed states: "depression with flight of ideas" and "excited depression". World J. Biol. Psychiatry 5 (2004) 107-113
7. Akiskal H.S., and Benazzi F. Optimizing the detection of bipolar II disorder in outpatient private practice: toward a systematization of clinical diagnostic wisdom. J. Clin. Psychiatry 66 (2005) 914-921
8. Akiskal H.S., Benazzi F., Perugi G., and Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord. 85 (2005) 245-258
9. Balazs J., Benazzi F., Rihmer Z., Rihmer A., Akiskal K.K., and Akiskal H.S. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91 (2006) 133-138
10. Beasley C.M., Sayler M.E., Weiss A.M., and Potvin J.H. Fluoxetine: activating and sedating effects at multiple fixed doses. J. Clin. Psychopharmacol. 12 (1992) 328-333
11. Benazzi F. Depression with racing thoughts. Psychiatry Res. 120 (2003) 273-282
12. Benazzi F. Family history validation of a definition of mixed depression. Compr. Psychiatry 46 (2005) 159-166
13. Benazzi F., and Akiskal H.S. Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: the relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J. Affect. Disord. 67 (2001) 115-122
14. Benazzi F., and Akiskal H.S. Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J. Affect. Disord. 73 (2003) 33-38
15. Bottlender R., Sato T., Kleindienst N., Strausz A., and Moller H.-J. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J. Affect. Disord. 78 (2004) 149-152
16. Busch K.A., Fawcett J., and Jacobs D.G. Clinical correlates of inpatient suicide. J. Clin. Psychiatry 64 (2003) 14-19
17. Dilsaver S.C., Benazzi F., Rihmer Z., Akiskal K.K., and Akiskal H.S. Gender, suicidality and bipolar mixed states in adolescents. J. Affect. Disord. 87 (2005) 11-16
18. Dunner D.L., and Tay K.L. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr. Psychiatry 34 (1993) 303-307
19. Fawcett J., Scheftner W., Clark D., Hedeker D., Gibbons R., and Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am. J. Psychiatry 144 (1987) 35-40
20. Fawcett J., Busch K.A., Jacobs D., Kravitz H.M., and Fogg L. Suicide: a four-pathway clinical-biochemical model. Ann. N. Y. Acad. Sci. 836 (1997) 288-301
21. FDA: http://www.fda.gov/cder/drug/antidepressants/PI_template.pdf(accessed January 2006a).
22. FDA: http://www.fda.gov/cder/drug/antidepressants/MG_template.pdf(accessed January 2006b).
23. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV) (1997), American Psychiatric Press, Washington, DC
24. Ghaemi S.N., Ko J.Y., and Goodwin F.K. "Cade's Disease" and beyond: misdiagnosis, antidepressant use, and proposed definition for bipolar spectrum disorder. Can. J. Psychiatry 47 (2002) 125-134
25. Hammad T.A., Laughren T., and Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry 63 (2006) 332-339
26. Healy D. Lines of evidence on the risk of suicide with selective serotonine reuptake inhibitors. Psychother. Psychosom. 72 (2003) 71-79
27. Himmelhoch J.M., Mulla D., Neil J.F., Detre T.P., and Kupfer D.J. Incidence and significance of mixed affective states in a bipolar population. Arch. Gen. Psychiatry 33 (1976) 1062-1066
28. Hosmer A.W., and Lemeshow S. Applied Logistic Regression (2000), John Wiley & Sons, Inc., New York
29. Koukopoulos A., Albert M.J., Sani G., Koukopoulos A.E., and Girardi P. Mixed depressive states: nosologic and therapeutic issues. Int. Rev. Psychiatry 17 (2005) 21-37
30. Maj M., Pirozzi R., Magliano L., and Bartoli L. Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome. Am. J. Psychiatry 160 (2003) 2134-2140
31. Mann J.J., Emslie G., Baldessarini R.J., Beardslee W., Fawcett J.A., Goodwin F.K., Leon A.C., Meltzer H.Y., Ryan N.D., Shaffer D., and Wagner K.D. ACNP task force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 31 (2006) 473-492
32. March J., Silva S., Petrycki S., Curry J., Wells K., Fairbank J., Burns B., Domino M., McNulty S., Vitiello B., and Severe J. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 292 (2004) 807-820
33. Maser J.D., Akiskal H.S., Zeller P., Scheftner W., Mueller T., Endicott J., Solomon D., and Clayton P. Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behavior? A 14-year prospective study. Suicide Life-Threat. Behav. 32 (2002) 10-32
34. Perugi G., Akiskal H.S., Micheli C., Toni C., and Madaro D. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J. Affect. Disord. 67 (2001) 105-114
35. Rihmer Z., and Kiss K. Bipolar disorders and suicide risk. Clin. Approach. Bipolar Disord. 1 (2002) 15-21
36. Rihmer Z., and Akiskal H.S. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord. 94 (2006) 3-13
37. Sato T., Bottlender R., Schroter A., and Moller H.-J. Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum. Acta Psychiatr. Scand. 107 (2003) 268-274
38. Simon G.E., Savarino J., Operskalski B., and Wang P.S. Suicide risk during antidepressant treatment. Am. J. Psychiatry 163 (2006) 41-47
39. Simpson S.G., McMahon F.J., McInnis M.G., MacKinnon D.F., Edwin D., Folstein S.E., and DePaulo J.R. Diagnostic reliability of bipolar II diagnosis. Arch. Gen. Psychiatry 59 (2002) 736-740
40. Tollefson G.D., Greist J.H., Jefferson J.W., Heiligenstein J.H., Sayler M.E., Tollefson S.L., and Koback K. Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine. J. Clin. Psychopharmacol. 14 (1994) 385-391
41. Weissman M.M., Wickramaratne P., Adams P., Wolk S., Verdeli H., and Olfson M. Brief screening for family psychiatric history. The family history screen. Arch. Gen. Psychiatry 57 (2000) 675-682
42. Williams J.B.W., Terman M., Link M.J., Amira L., and Rosenthal N.E. Hypomania Interview Guide (including Hyperthymia). Current Assessment Version (HIGH-C). Clinical Assessment Tools Packet, Center for Environmental Therapeutics, Norwood, NJ (1994)